Transformation in the Pharmaceutical Industry: Transformation-Induced Quality Risks—A Survey

References

1. 1.↵
   1. Shafiei N.,
   2. Ford J. L.,
   3. Morecroft C. W.,
   4. Lisboa P. J.,
   5. Taylor M. J.

   Characterization of the evolution of the pharmaceutical regulatory environment. PDA J. Pharm. Sci. Technol. Accepted for publication April 2013.
2. 2.↵
   1. Shafiei N.,
   2. Ford J. L.,
   3. Morecroft C. W.,
   4. Lisboa P. J.,
   5. Taylor M. J.,
   6. Mouzughi Y.

   Transformation in the Pharmaceutical Industry—a systematic review of the literature. PDA J. Pharm. Sci. Technol. 2013; 67, 105–122.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Shafiei N.,
   2. Ford J. L.,
   3. Morecroft C. W.,
   4. Lisboa P. J.,
   5. Taylor M. J.,
   6. Mouzughi Y.

   Transformation in the pharmaceutical Industry—a systematic analysis of the operational evidence. PDA J. Pharm. Sci. Technol. Accepted for publication March 2013.
4. 4.↵
   1. Robson C.

   Real World Research, 2nd ed.; Blackwell Publishing: Oxford, 2002.
5. 5.↵
   1. Carmines E. G.,
   2. Zeller R. A.

   Reliability and validity Assessment. London, England: SAGE Publications; 1979.
6. 6.↵
   1. Leal J.,
   2. Wordsworth S.,
   3. Legood R.,
   4. Blair E.

   Eliciting Expert Opinion for Economic Models: An Applied Example. Value in Health 2007, 10(3), 195–203.

   OpenUrlPubMed
7. 7.↵
   1. Wallis G. B.

   Cognitive Interviewing—A “How To” Guide; National Cancer Institute: Bethesda, MD, 1999; http://appliedresearch.cancer.gov/areas/cognitive/guides.html. Accessed June 8, 2011.
8. 8.↵
   1. Gliem J. A.,
   2. Gliem R.

   Calculating, interpreting, and reporting Cronbach's alpha reliability coefficient for Likert-type scales. IUPUI Scholar Works 2003, http://hdl.handle.net/1805/344. Accessed June 8, 2011.